Screener
Rapport Therapeutics, Inc. RAPP Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total current assets | 446,856 | 498,561 |
| Property and equipment, net | 2,337 | 2,976 |
| Operating lease right of use asset, net | 8,732 | 9,909 |
| Other assets | 1,057 | 985 |
| Total assets | $458,982 | $512,431 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $2,796 | $4,190 |
Item 1. Financial Statements.
FAQ
- What is Rapport Therapeutics, Inc.'s other non-current assets?
- Rapport Therapeutics, Inc. (RAPP) reported other non-current assets of $1.06M in Q2 2026.
- How has Rapport Therapeutics, Inc.'s other non-current assets changed year-over-year?
- Rapport Therapeutics, Inc.'s other non-current assets increased by 2.2% year-over-year, from $1.03M to $1.06M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s other non-current assets?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s other non-current assets has grown at a 33.7% compound annual growth rate (CAGR), from $551K to $985K.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Rapport Therapeutics, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude